glp-1 drug shortages How drugs are used GLP-1 Drugs Mounjaro, Zepbound, Wegovy

[DOI] [PubMed] [Google Scholar] 129.Nauck MA, Mller TD

A study shows that GLP-1 receptor agonists show a notably reduced incidence of primary open-angle glaucoma (POAG), ocular hypertension, and the requirement for first-line glaucoma treatments compared to metformin in individuals with type 2 diabetes (80)

Clinical evidence supporting the anti-inflammatory effects of GLP-1 receptor agonists comes primarily from cardiovascular outcome trials and mechanistic studies, though most research has examined standard therapeutic doses rather than specifically low-dose regimens

The complex interplay between diabetes and cancer risk presents additional challenges in understanding the role of GLP-1RAs